Search company, investor...
Pear Therapeutics company logo

Pear Therapeutics

Founded Year



Asset Sale | AssetsPurchased

Total Raised


About Pear Therapeutics

Pear Therapeutics discovers, develops, and delivers clinically-validated Prescription Digital Therapeutics to provide outcomes for patients, engagement and tracking tools for clinicians, and solutions for payers. The company was founded in 2013 and is based in Boston, Massachusetts.

Headquarters Location

200 State St

Boston, Massachusetts, 02109,

United States


Missing: Pear Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Pear Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Pear Therapeutics

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Pear Therapeutics in 5 CB Insights research briefs, most recently on Jan 24, 2023.

Expert Collections containing Pear Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pear Therapeutics is included in 9 Expert Collections, including Mental Health Tech.


Mental Health Tech

1,285 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.


Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry


Sleep Health & Wellness

804 items

These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.


Medical Devices

12,358 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Pear Therapeutics Patents

Pear Therapeutics has filed 13 patents.

The 3 most popular patent topics include:

  • Psychiatric diagnosis
  • Graphical user interface elements
  • Cognitive behavioral therapy
patents chart

Application Date

Grant Date


Related Topics




Data security, Computer security, Immunology, Data management, Medical specialties


Application Date


Grant Date



Related Topics

Data security, Computer security, Immunology, Data management, Medical specialties



Latest Pear Therapeutics News

Pear Therapeutics: 4 companies want pieces of bankrupt company

May 22, 2023

The potential sales price is a dramatic turn for the company, which went public in December 2021 through special purpose acquisition company Thimble Point Acquisition in a deal that valued it at $1.6 billion. Pear, which reported $13 million in revenue last year and lost around $123 million, filed for bankruptcy in April . In the Chapter 11 filing, it listed $65.6 million in assets and $51 million in debt. Pear developed solutions for opioid use disorder and insomnia, which were among the first digital therapeutics to receive clearance from the Food and Drug Administration. But it ran into challenges with payer reimbursement . Founder and CEO Corey McCann said in a LinkedIn post shortly after it filed for bankruptcy that the company had failed because of denials from payers and market conditions. According to court filings, Click Therapeutics, a digital therapeutics company, seeks to buy different patents from Pear for $70,000. Nox Health, a company that develops diagnostics for sleeping, wants to buy Pear’s insomnia therapeutics product for $3.9 million. Welt, a digital biomarkers company, plans to buy Pear’s migraine-related assets for $50,000. Harvest Bio seeks to acquire Pear’s substance use disorder therapeutic as well as various trademarks, licenses and patients for $2.03 million. Related Articles

Pear Therapeutics Frequently Asked Questions (FAQ)

  • When was Pear Therapeutics founded?

    Pear Therapeutics was founded in 2013.

  • Where is Pear Therapeutics's headquarters?

    Pear Therapeutics's headquarters is located at 200 State St, Boston.

  • What is Pear Therapeutics's latest funding round?

    Pear Therapeutics's latest funding round is Asset Sale.

  • How much did Pear Therapeutics raise?

    Pear Therapeutics raised a total of $334.94M.

  • Who are the investors of Pear Therapeutics?

    Investors of Pear Therapeutics include Harvest Bio, WELT, Click Therapeutics, Nox Health, SoftBank and 17 more.

  • Who are Pear Therapeutics's competitors?

    Competitors of Pear Therapeutics include BlueSignum, opiAID, Feel Therapeutics, metaMe Health, HelloBetter, GrayMatters Health, Twill, Amalgam Rx, WonderLab, Valera Health and 30 more.

Compare Pear Therapeutics to Competitors

Click Therapeutics Logo
Click Therapeutics

Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet medical needs. It enables change within individuals and can be used independently or in conjunction with biomedical treatments. The company was founded in 2012 and is based in New York, New York.

Twill Logo

Twill provides digital therapeutics and care delivery models focused on mental and physical health. It partners with enterprises, pharma companies, and health plans to create new products that help support and manage specific mental and physical conditions. The company was formerly known as Happify Health and Happify. It was founded in 2012 and is based in New York, New York.


GAIA develops digital therapy solutions that offer physicians, therapists, payers, and patients the same effect sizes, similar safety profiles, and equal levels of convenience as found in well-developed, pharmaceutical solutions. Its product lines include Velibra, a platform for excessive fears and worries; Elevida, an online program for people with MS fatigue; Deprexis, an online platform for people with depression; Vorvida, a tool to reduce alcohol consumption; Optimune, offering digital therapy for breast cancer; and Levidex, a companion for multiple sclerosis. The company was founded in 1997 and is based in Hamburg, Germany.

BrightInsight Logo

BrightInsight provides a digital health care solutions. The company provides digital health solutions for cardiovascular diseases, diabetes, immunology, oncology, and more. It was formerly known as Flex Digital Health. The company was founded in 2018 and is based in San Jose, California.

Ellipsis Health Logo
Ellipsis Health

Ellipsis Health develops artificial intelligence (AI) generated vocal biomarker technology. It helps in identifying, assessing, and monitoring mental health with a short voice sample, its technology determines the severity of anxiety and depression. Ellipsis Health was founded in 2017 and is based in San Francisco, California.

Big Health Logo
Big Health

Big Health develops a digital healthcare portal for mental health issues. It offers digital therapeutics services and automated behavioral programs. The company provides Sleepio for users in need of sleep issues. It was founded in 2010 and is based in San Francisco, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.